Whole-genome sequencing of Lactobacillus helveticus HP-B1137 and its biotransformation capacity toward calycosin-7-O-β-D-glucoside
- 1College of Pharmacy, Heze University , ,
Abstract
Introduction: Astragalus , as a traditional tonic herb, has alycosin-7-O-β-D-glucoside as one of its main active components.
Methods: In this study, a strain of Lactobacillus helveticus HP-B1137 was isolated from raw milk in Mudan District, Heze City, Shandong Province. The probiotic properties, and ability to biotransform calycosin-7-O-β-D-glucoside were systematically evaluated.
Results and discussion: Genome analysis revealed that HP-B1137 possesses a circular chromosome (2,098,901 bp) comprising 2,161 CDs, 63 tRNAs and 12 rRNAs. Two circular plasmids were also identified, with sizes of 23,906 bp and 6,414 bp and GC contents of 38.54 and 34.49%, respectively. Functional annotation showed that the strain is rich in carbohydrate metabolism genes, with 29 glycoside hydrolase genes annotated by the CAZy database, providing a genetic basis for its glycoside-hydrolyzing capability. In vitro probiotic tests demonstrated that the strain maintained high viable cell counts after 3 min of heat treatment at 50 °C, achieved a survival rate of 108.33% after 150 min in artificial gastric juice at pH 2.7. It also inhibited 11 pathogenic bacteria, producing inhibition zones ranging from 9.83 to 16.37 mm. Whole-cell transformation experiments indicated that HP-B1137 could nearly completely convert 0.5 mg/mL calycosin-7-O-β-D-glucoside into calycosin within 36 h. Further cloning and expression of the recombinant BgsH enzyme revealed optimal reaction conditions at 37 °C and pH 7.0; under optimized conditions—0.1% substrate concentration, 10 U/mL enzyme activity, and 12-h incubation—the conversion efficiency exceeded 96.3%. In summary, L. helveticus HP-B1137 is a functional strain integrating efficient biotransformation, excellent probiotic characteristics, tolerance to extreme environments, and broad-spectrum antimicrobial activity, showing significant potential for developing functional foods derived from Astragalus and green bio-manufacturing of active aglycones.
Related
- 133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma
- Structure-based computational prioritization of Emodin-8-glucoside as a candidate ligand for the VEGFR1 kinase domain in the context of placenta previa
- Multienzyme cascade biotransformation of L-Tyrosine to Danshensu by engineered Escherichia coli
- A microbiota-bile acid-immune axis orchestrates intestinal antiviral defense: CDCA-to-UDCA biotransformation by Limosilactobacillus reuteri LRM2293 is associated with PEDV resistance.
- Biotransformation process of fluoroquinolones by the ligninolytic enzymes of Phanerochaete chrysosporium
BibTeX
@article{zhang2026wholegenome,
title = {{Whole-genome sequencing of Lactobacillus helveticus HP-B1137 and its biotransformation capacity toward calycosin-7-O-β-D-glucoside}},
author = {Shu-Hang Zhang and Lan-Fang Li and Zhao-Sen Fan and Shao-Yang Hou},
journal = {Frontiers in microbiology},
year = {2026},
month = sep,
doi = {10.3389/fmicb.2026.1962579},
url = {https://europepmc.org/article/PMC/PMC13661924},
note = {CC BY},
}
RIS
TY - JOUR
TI - Whole-genome sequencing of Lactobacillus helveticus HP-B1137 and its biotransformation capacity toward calycosin-7-O-β-D-glucoside
AU - Shu-Hang Zhang
AU - Lan-Fang Li
AU - Zhao-Sen Fan
AU - Shao-Yang Hou
PY - 2026
DA - 2026/09/30
JO - Frontiers in microbiology
DO - 10.3389/fmicb.2026.1962579
UR - https://europepmc.org/article/PMC/PMC13661924
AB - Introduction: Astragalus , as a traditional tonic herb, has alycosin-7-O-β-D-glucoside as one of its main active components. Methods: In this study, a strain of Lactobacillus helveticus HP-B1137 was isolated from raw milk in Mudan District, Heze City, Shandong Province. The probiotic properties, and ability to biotransform calycosin-7-O-β-D-glucoside were systematically evaluated. Results and discussion: Genome analysis revealed that HP-B1137 possesses a circular chromosome (2,098,901 bp) comprising 2,161 CDs, 63 tRNAs and 12 rRNAs. Two circular plasmids were also identified, with sizes of 23,906 bp and 6,414 bp and GC contents of 38.54 and 34.49%, respectively. Functional annotation showed that the strain is rich in carbohydrate metabolism genes, with 29 glycoside hydrolase genes annotated by the CAZy database, providing a genetic basis for its glycoside-hydrolyzing capability. In vitro probiotic tests demonstrated that the strain maintained high viable cell counts after 3 min of heat treatment at 50 °C, achieved a survival rate of 108.33% after 150 min in artificial gastric juice at pH 2.7. It also inhibited 11 pathogenic bacteria, producing inhibition zones ranging from 9.83 to 16.37 mm. Whole-cell transformation experiments indicated that HP-B1137 could nearly completely convert 0.5 mg/mL calycosin-7-O-β-D-glucoside into calycosin within 36 h. Further cloning and expression of the recombinant BgsH enzyme revealed optimal reaction conditions at 37 °C and pH 7.0; under optimized conditions—0.1% substrate concentration, 10 U/mL enzyme activity, and 12-h incubation—the conversion efficiency exceeded 96.3%. In summary, L. helveticus HP-B1137 is a functional strain integrating efficient biotransformation, excellent probiotic characteristics, tolerance to extreme environments, and broad-spectrum antimicrobial activity, showing significant potential for developing functional foods derived from Astragalus and green bio-manufacturing of active aglycones.
SN - 1664-302X
ER -